Skip to main content

Loading market data...

BNTX

BioNTech SE

NASDAQ • United states

$90.20

+$0.99

(+1.11%)

Source: Yahoo Finance · Quote time Oct 20, 2026 18:48 GMT+0000

Catalyst Evidence

No verified catalyst stored yet

Click “View” to see the stored chain of evidence (if available).

Management
Credibility
Score

BioNTech SE (BNTX)

Unavailable

Quotes may be delayed

$22.66B

Market Cap

1,101,022

Volume

Unavailable

P/E Ratio

Unavailable

Div Yield

BioNTech SE Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: AN DER GOLDGRUBE 12, MAINZ, 2M
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

16 May 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in BioNTech SE.

15 May 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in BioNTech SE.

19 Dec 2025

BioNTech SE tender offer filing

BioNTech SE filed Schedule TO-T/A (amended third-party tender offer).

4 Dec 2025

BioNTech SE tender offer filing

BioNTech SE filed Schedule TO-T/A (amended third-party tender offer).

4 Dec 2025

BioNTech SE business combination filing

BioNTech SE filed Form 425 (communications about a business combination).

Capital Structure & Financial Position

Financial strength and liquidity analysis

Verified Capital Structure Unavailable

Balance-sheet, credit-rating, debt, and capital-activity data require sourced financial statement ingestion.

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Verified Financial Statements Unavailable

Verified financial statement data is not ingested for this stock yet.

Analyst Consensus

Buy

Target: $125.85

39.5% upside potential

📈

Strong Buy

Unavailable

👍

Buy

11

⏸️

Hold

4

📉

Sell

0

15 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 20 Oct 2026, 18:48 UTC Targets range 96.00–140.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

9

Oct 2026

Sahin Ugur

Chief Executive Officer, 10% owner

Open-market sale

$95.37 per share

36,209 shares

8

Oct 2026

Sahin Ugur

Chief Executive Officer, 10% owner

Open-market sale

$92.31 per share

27,000 shares

7

Oct 2026

Sahin Ugur

Chief Executive Officer, 10% owner

Open-market sale

$95.86 per share

24,000 shares

6

Oct 2026

Sahin Ugur

Chief Executive Officer, 10% owner

Open-market sale

$96.81 per share

21,000 shares

5

Oct 2026

Sahin Ugur

Chief Executive Officer, 10% owner

Open-market sale

$97.23 per share

72,000 shares

2

Oct 2026

Sahin Ugur

Chief Executive Officer, 10% owner

Open-market sale

$96.72 per share

17,000 shares

1

Oct 2026

Sahin Ugur

Chief Executive Officer, 10% owner

Open-market sale

$97.46 per share

17,000 shares

30

Sep 2026

Sahin Ugur

Chief Executive Officer, 10% owner

Open-market sale

$98.12 per share

32,000 shares

29

Sep 2026

Sahin Ugur

Chief Executive Officer, 10% owner

Open-market sale

$98.26 per share

34,000 shares

28

Sep 2026

Sahin Ugur

Chief Executive Officer, 10% owner

Open-market sale

$98.47 per share

34,000 shares

Top Shareholders

Fmr Llc

7,571,805 shares

32.624% change

6/30/2026

Primecap Management Co/Ca/

3,772,031 shares

-0.571% change

6/30/2026

Dodge & Cox

3,677,591 shares

0.022% change

6/30/2026

Flossbach Von Storch Se

2,226,138 shares

-39.512% change

6/30/2026

T. Rowe Price Investment Management, Inc.

2,065,456 shares

-64.73% change

6/30/2026

Blackrock, Inc.

1,854,966 shares

11.869% change

6/30/2026

Temasek Holdings (Private) Ltd

1,506,027 shares

0% change

6/30/2026

Bnp Paribas Financial Markets

1,319,517 shares

-20.116% change

6/30/2026

Logos Global Management Lp

1,015,000 shares

New% change

6/30/2026

Gsk Plc

889,824 shares

0% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 20 Oct 2026, 18:48 UTC· 1 day ago

Research coverage and investment tools

BioNTech SE (BNTX) is a stock listed on the Nasdaq in the United States, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). Its last price was US$90.20 on 20 Oct 2026. That is 24% of the way from its 52-week low of US$79.52 to its 52-week high of US$124.00. Its market capitalisation was US$22.66 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

SCHEDULE 13G/A · 16 May 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in BioNTech SE.
SCHEDULE 13G/A · 15 May 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in BioNTech SE.
SC TO-T/A · 19 Dec 2025 · Merger or acquisition Tender offer

BioNTech SE tender offer filing (opens in a new tab)

BioNTech SE filed Schedule TO-T/A (amended third-party tender offer).
SC TO-T/A · 4 Dec 2025 · Merger or acquisition Tender offer

BioNTech SE tender offer filing (opens in a new tab)

BioNTech SE filed Schedule TO-T/A (amended third-party tender offer).
425 · 4 Dec 2025 · Merger or acquisition Announced

BioNTech SE business combination filing (opens in a new tab)

BioNTech SE filed Form 425 (communications about a business combination).

Insider	Date	Transaction	Shares	Average price	Filing
Sahin Ugur Chief Executive Officer, 10% owner	9 Oct 2026	Open-market sale (S)	−36,209	$95.37	Form 4 (opens in a new tab)
Sahin Ugur Chief Executive Officer, 10% owner	8 Oct 2026	Open-market sale (S)	−27,000	$92.31	Form 4 (opens in a new tab)
Sahin Ugur Chief Executive Officer, 10% owner	7 Oct 2026	Open-market sale (S)	−24,000	$95.86	Form 4 (opens in a new tab)
Sahin Ugur Chief Executive Officer, 10% owner	6 Oct 2026	Open-market sale (S)	−21,000	$96.81	Form 4 (opens in a new tab)
Sahin Ugur Chief Executive Officer, 10% owner	5 Oct 2026	Open-market sale (S)	−72,000	$97.23	Form 4 (opens in a new tab)
Sahin Ugur Chief Executive Officer, 10% owner	2 Oct 2026	Open-market sale (S)	−17,000	$96.72	Form 4 (opens in a new tab)
Sahin Ugur Chief Executive Officer, 10% owner	1 Oct 2026	Open-market sale (S)	−17,000	$97.46	Form 4 (opens in a new tab)
Sahin Ugur Chief Executive Officer, 10% owner	30 Sep 2026	Open-market sale (S)	−32,000	$98.12	Form 4 (opens in a new tab)
Sahin Ugur Chief Executive Officer, 10% owner	29 Sep 2026	Open-market sale (S)	−34,000	$98.26	Form 4 (opens in a new tab)
Sahin Ugur Chief Executive Officer, 10% owner	28 Sep 2026	Open-market sale (S)	−34,000	$98.47	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Fmr Llc	6/30/2026	7,571,805	32.624%
Primecap Management Co/Ca/	6/30/2026	3,772,031	-0.571%
Dodge & Cox	6/30/2026	3,677,591	0.022%
Flossbach Von Storch Se	6/30/2026	2,226,138	-39.512%
T. Rowe Price Investment Management, Inc.	6/30/2026	2,065,456	-64.73%
Blackrock, Inc.	6/30/2026	1,854,966	11.869%
Temasek Holdings (Private) Ltd	6/30/2026	1,506,027	0%
Bnp Paribas Financial Markets	6/30/2026	1,319,517	-20.116%
Logos Global Management Lp	6/30/2026	1,015,000	New
Gsk Plc	6/30/2026	889,824	0%

Previous close: 89.21 USD
Day range: 88.68 – 90.29 USD
52-week range: 79.52 – 124.00 USD
Volume: 1,101,022
Market cap: $22.66B
Average volume: 1,251,093
Shares outstanding: 251.20M
Beta (5Y monthly): 1.31

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 20 Oct 2026, 18:48 UTC· 1 day ago

Average volume, P/E and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 06:23 UTC· 46 minutes ago

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding.

This research is not available for BNTX yet

Financial statements
Balance sheet
Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.